Download PDF
Hamostaseologie 1983; 03(04): 131-139
DOI: 10.1055/s-0038-1656629
Originalarbeiten
Schattauer GmbH

Veränderungen von Plättchenfunktion und plasmatischer Gerinnung bei Diabetes mellitus

H. K. Breddin
1   Aus dem Zentrum der Inneren Medizin, Abteilung für Angiologie der Johann-Wolfgang-Goethe-Universität, Frankfurt am Main
,
H. J. Krzywanek
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Abastado M, Donmenc J, Prost R, Bara L, Samama M, Derot M, Bousser J. Etude de l’activité fibrinolytique et des fonctions plaquettaires dans le premier temps de l’hémostase chez les diabetiques. Presse médical 1968; 76: 1317-1320.
    PubMedGoogle Scholar
  • 2 Abrahamsen A. F. Platelet survival studies in man. Scand. J. Haemat., Suppl. 1968: 3
    PubMedGoogle Scholar
  • 3 Aimer L. O, Pandolfi M, Nilsson I. M. Diabetic retinopathy and the fibrinolytic system. Diabetes 1975; a 24 (15) S.529-534.
    CrossrefPubMedGoogle Scholar
  • 4 Aimer L. O, Nilsson J. M. On fibrinolysis in diabetes mellitus. Acta med. Scand 1975; b 198: 101-106.
    PubMedGoogle Scholar
  • 5 Aimer L. O, Pandolfi M. Fibrinolysis and diabetic retinopathy. Diabetes 1976; 25 NR. Suppl (Suppl. 02) S.807-810.
    PubMedGoogle Scholar
  • 6 Almer L. O. The fibrinolytic system in diabetes mellitus. Sixth Congr. on Thrombosis of the mediterranean league against thromboembolic diseases, Monte Carlo, Abstr. 1980: 120
    Google Scholar
  • 7 Aimer L. O, Sundkvist G, Lilja B. Endothelial factors, the temperature and leg circulation in diabetics with and without autonomic neuropathy. Thrombos. Res 1982; 26: 119-128.
    CrossrefPubMedGoogle Scholar
  • 8 Badawi H, El-Sawy M, Mikhail M, Nomeiri A. M, Tewfik S. Platelets, coagulation and fibrinolysis in diabetic and nondiabetic patients with quiescent coronary heart disease. Angiology 1970; 21: 511-519.
    CrossrefPubMedGoogle Scholar
  • 9 Banerjee R. N, Sahni A. L, Kumar V. Fibrinocoagulopathy in maturity onset diabetes mellitus and atherosclerosis. Thrombos. Diathes. Haemorrh 1973; 30: 123-132.
    PubMedGoogle Scholar
  • 10 Banerjee R. N, Sahni A. L, Kumar V, Arya M. Antithrombin III deficiency in maturity onset diabetes mellitus and atherosclerosis. Thrombos. Diathes. Haemorrh 1974; 31: 339-345.
    PubMedGoogle Scholar
  • 11 Bender N, Ziemen M, Friedrich J, Kirchmaier C. Erhöhter Beta-Thromboglobulinspie-gel im Plasma von Diabetikern und von Patienten mit arterieller Verschlußkrankheit. In Schmipf K. (Hrsg.) Fibrinogen, Fibrin und Fibrinkleber. Nebenwirkungen der Therapie mit Gerinnungsfaktorenkonzentraten S.535-540. Schattauer; Stuttgart – New York: 1980
    Google Scholar
  • 12 Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J. Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 1975; 11: 307-312.
    CrossrefPubMedGoogle Scholar
  • 13 Bern M. M. Platelet functions in diabetes mellitus. Diabetes 1978; 27: 342-350.
    CrossrefPubMedGoogle Scholar
  • 14 Bern M. M, Rand L, Peirce C, Fraser M, Erickson S, White K, Arkin C, Gallavan M. Effects of platelet function, Factor VIII, v. Willebrand’s factor and fibrinolysis on development of diabetic retinopathy after long term diabetes mellitus. Monte Carlo, Sixth Congr. on thrombosis of the mediterranean, league against thromboembolic diseases. Abstr. 1980: 158
    PubMedGoogle Scholar
  • 15 Bern M. M, Cassani M. P, Horton J, Rand L, Davis G. Changes of fibrinolysis and factor VIII coagulant, antigen and ristocetin cofac-tor in diabetes mellitus and atherosclerosis. Thrombos. Res 1980; 19: 831-839.
    CrossrefPubMedGoogle Scholar
  • 16 Bizzi B, Leone G, Boni P. Basic considerations on treatment of increased platelet aggregation in diabetic vasculopathic patients. Acta diabet. lat 1974; 11: 437-445.
    CrossrefPubMedGoogle Scholar
  • 17 Borkenstein M. H, Muntean W. E. Elevated factor VIII activity and factor VHI-related antigen in diabetic children without vascular disease. Diabetes 1982; 31: 1006-1009.
    CrossrefPubMedGoogle Scholar
  • 18 Borsey D. Q, Dawes J, Fraser D. M, Prowse C. V, Elton R. A, Clarke B. F. Plasma beta-thromboglobulin in diabetes mellitus. Diabetologia 1980; 18: 353-357.
    PubMedGoogle Scholar
  • 19 Breddin K. Über die gesteigerte Thrombozy-tenagglutination bei Gefäßkrankheiten. Schweiz. med. Wschr 1965; 95: 655-660.
    PubMedGoogle Scholar
  • 20 Breddin K. Thrombozytenagglutination bei Gefäßkrankheiten. Med. Welt 1966; 17: 2322-2324.
    PubMedGoogle Scholar
  • 21 Breddin K, Krzywanek H. J, Ziemen M. Enhanced platelet aggregation as a risk factor for vascular disease and its thromboembolic complications. Acta clin. Belg 1975; 30: 195-203.
    CrossrefPubMedGoogle Scholar
  • 22 Breddin K, Bauke J. Thrombozytenagglutination und Gefäßkrankheiten. 1965; Blut 11: 144-164.
    CrossrefPubMedGoogle Scholar
  • 23 Breddin K, Krzywanek H. J, Ziemen M. Methods for the evaluation of the risk of thrombosis in patients with atherosclerosis. Rome, Ed. C. E. P. S., 1976, in: Advances in coagulation, fibrinolysis, platelet aggregation and atherosclerosis. S. 124-139.
    PubMedGoogle Scholar
  • 24 Breddin K, Grun H, Krzywanek H. J, Schremmer P. On the measurement of spontaneous platelet aggregation. The platelet aggregation test III. Methods and first clinical results. Thrombos. Haemostas 1976; 35: 669-691.
    PubMedGoogle Scholar
  • 25 Breddin K, Krzywanek H. J. Thrombocyte function and age. Studies with healthy volunteers, diabetics and patients with vascular disease. In Effert S, Meyer-Erkelenz J. D. (Eds.) Problems arising at the borders of natural and artificial blood vessels Springer; Berlin – Heidelberg – New York: 1976: S. 43-50.
    Google Scholar
  • 26 Brooks A. M. V, Hussein S, Chesterman C. N, Martin J. F, Alford F. P, Penington D. G. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy. Thromb. Haemostas 1983; 49: 123-127.
    PubMedGoogle Scholar
  • 27 Burrows A. W, Chavin S. I, Hockaday T. D. R. Plasma-Betathromboglobulin concentrations in diabetes mellitus. Lancet 1978; 1: 235-237.
    PubMedGoogle Scholar
  • 28 Cagliero E, Porta M, Cousins S, Kohner E. M. Increased platelet volume in diabetic retinopathy. Haemostasis 1982; 12: 293-299.
    PubMedGoogle Scholar
  • 29 Campbell I. W, Dawes J, Fraser D. M, Pepper D. S, Clarke B. F, Duncan L. J. P, Cash J. D. Plasma beta-thromboglobulin in diabetes mellitus. Diabetes 1977; 26: 1175-1177.
    CrossrefPubMedGoogle Scholar
  • 30 Cash J. D, McGill R. C. Fibrinolytic response to moderate exercise in young male diabetics and non-diabetics. J. Clin. Path 1969; 22: 32-35.
    PubMedGoogle Scholar
  • 31 Coccheri S, Palareti G, Poggi M. Hemorheology and blood clotting in diabetic retinopathy. Monte Carlo, Sixth Congr. on Thrombosis of the mediterranean league against thromboembolic diseases. Abstr. 1980: 157
    PubMedGoogle Scholar
  • 32 Coller B. S, Frank R. M, Milton R. C, Gralnick H. R. Plasma cofactors of platelet function: Correlation with diabetic retinopathy and hemoglobins A 1 a–c. Ann. Intern. Med 1978; 88: 311-316.
    CrossrefPubMedGoogle Scholar
  • 33 Colwell J. A, Chambers A, Laimins M. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus. Diabetes 1975; 24: 684-687.
    CrossrefPubMedGoogle Scholar
  • 34 Colwell J. A, Halushka P. V, Sarji K, Levine J, Sagel J, Raghavani C. B, Nair M. G. Altered platelet function in diabetes mellitus. Diabetes 1976; 25 Suppl (Suppl. 02) 826-831.
    PubMedGoogle Scholar
  • 35 Colwell J. A, Sagel J, Crook L, Chambers A, Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrom-bocytes in diabetic subjects with and without vascular disease. Metabolism 1977; 26: 279-285.
    CrossrefPubMedGoogle Scholar
  • 36 Colwell J. A, Halushka P. V, Sarji K. E, Sagel J. Platelet function and diabetes mellitus. Med. clin. J. Amer 1978; 62: 753-766.
    PubMedGoogle Scholar
  • 37 Colwell J. A, Gonzalez J, Sarji K. E, Sarji R. M. G, Sagel J. Effect of metabolic control with insulin on plasma von Willebrand factor activity, growth hormone, and platelet aggregation in diabetes mellitus. Thromb. Haemostas 1979; 42: 382
    PubMedGoogle Scholar
  • 38 Colwell J. A, Halushka P. V, Sarji K. E, Lopes-Virella M. F, Sagel J. Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Arch. intern. Med 1979; 139: 225-230.
    CrossrefPubMedGoogle Scholar
  • 39 Colwell J. A, Nair R. M, Halushka P. V, Rogers C, Whetsell A, Sagel J. Platelet adhesion and aggregation in diabetes mellitus. Metabolism 1979; 28: 394-400.
    CrossrefPubMedGoogle Scholar
  • 40 Colwell J. A, Halushka P. V. Platelet function in diabetes mellitus. Brit. J. Haemat 1980; 44: 521-526.
    CrossrefPubMedGoogle Scholar
  • 41 Corbella E, Miragliotta G, Masperi R, Villa S, Binio A, de Gaetano G, Chiumello G. Platelet aggregation and antithrombin III levels in diabetic children. Haemostasis 1979; 8: 30-37.
    PubMedGoogle Scholar
  • 42 Corrall R. J. M, Webber R. G, Frier B. M. Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism. Brit. J. Haemat 1980; 44: 301-305.
    CrossrefPubMedGoogle Scholar
  • 43 Cretar D, Parlotzky F, Savir H. Platelet aggregation in diabetic retinopathy. Acta haemat 1978; 60: 53-55.
    CrossrefPubMedGoogle Scholar
  • 44 D’Angelo A, Micossi P, Franchi F, Mannucci P. M. Production of platelet thromboxane B2 in non-insulin dependent diabetics: inhibition of the arachidonate enzymatic pathway in diabetic microangiopathy. Haemostasis 1982; 12: 89
    PubMedGoogle Scholar
  • 45 Dalsgaard-Nielsen J, Madsbad S, Hilsted J. Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects. Thromb. Haemostas 1982; 47: 254-258.
    PubMedGoogle Scholar
  • 46 Dassin E, Najean Y, Poirier O, Passa Ph, Bensoussan D. In vivo platelet kinetics in 31 diabetic patients. Correlation with the degree of vascular impairment. Thromb. Haemostas 1978; 40: 83-88.
    PubMedGoogle Scholar
  • 47 Davi G, Rini G. B, Averna M, Novo S, Di Fede G, Mattina A, Notarbartolo A, Strano A. Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients. Haemostasis 1982; 12: 275-281.
    PubMedGoogle Scholar
  • 48 Davis J. W, Phillips P. E, Yue K. T. N, Lewis jr. H. D, Hartman C. R. Platelet aggregation. Adult-onset diabetes mellitus and coronary artery disease. JAMA 1978; 239: 732-734.
    CrossrefPubMedGoogle Scholar
  • 49 Egeberg O. The blood coagulability in diabetic patients. Scand. J. Clin. Lab. Invest 1963; 15: 533-538.
    CrossrefPubMedGoogle Scholar
  • 50 Elder G. E, Mayne E. E, Daly J. G, Kennedy A. L, Hadden D. R, Montgomery D. A. D, Weaver J. A. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy. Haemostasis 1980; 9: 288-296.
    PubMedGoogle Scholar
  • 51 Fearnley G. R, Chakrabarti R, Davis P. R. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischemic heart disease and obesity. Brit. Med. J 1963; I: 921-923.
    PubMedGoogle Scholar
  • 52 Ferguson J. C, Mackay N, Philip J. A. D, Summer D. J. Platelet and fibrinogen kinetic studies in diabetes mellitus. Brit. J. Haemat 1973; 25: 545
    PubMedGoogle Scholar
  • 53 Ferguson J. C, Mackay N, Philips A. O, Summer D. J. Determination of platelet and fibrinogen half-life with (75-Se) selenomethionine; studies in normal and in diabetic subjects. Clin. Sci. Molec. Med 1975; 49: 115-120.
    PubMedGoogle Scholar
  • 54 Fleischmann A. B, Bierenbaum M. L, Stier A, Somol H, Watson P. B. In vivo platelet function in diabetes mellitus. Thrombos. Res 1976; 9: 467-471.
    CrossrefPubMedGoogle Scholar
  • 55 Fuller J. H, Keen H, Jarrett R. J, Orner T, Meade T. W, Chakrabarti R, North W. R. S, Stierling Y. Haemostatic variables associated with diabetes and its complications. Brit. Med. J 1979; 2: 964-966.
    CrossrefPubMedGoogle Scholar
  • 56 Fuller J. H, Meade T. W, Keen H, Chakrabarti R, Jarrett R. J, North W. R. S, Omer T, Stierling Y. Haemostasis in diabetes and its relationship with diabetic complications. (Abstr.). Thrombos. Haemostas 1979; 42: 383
    PubMedGoogle Scholar
  • 57 Gamba C, Grignani G, Pacchiarini L, Geroldi D, Solerete B. S. Haemostatic abnormalities in diabetics with and without thromboembolic complications. Haemostasis 1982; 12: 164
    PubMedGoogle Scholar
  • 58 Ganda O. P. Pathogenesis of macrovascular disease in the human diabetic. Diabetes 1980; 29: 931-942.
    CrossrefPubMedGoogle Scholar
  • 59 Gandolfo G. M, De Angelis A, Torresi M. V. Determination of Antithrombin III activities by different methods in diabetic patients. Haemostasis 1980; 9: 15-19.
    PubMedGoogle Scholar
  • 60 Garcia-Conde J, Amado J. A, Merino J, Benet J. Prostaglandins and platelet function in diabetes. Thrombos. Haemostas 1979; 42: 335
    PubMedGoogle Scholar
  • 61 Gensini G. F, Abbate R, Favilla S, Neri Serneri G. G. Changes of platelet function and blood clotting in diabetes mellitus. Thromb. Haemostas 1979; 42: 983-993.
    PubMedGoogle Scholar
  • 62 Gerrard J. M, Stuart M. J, Rao G. H. R, Steffes M. W, Mauer S. M, Brown D. M, White J. G. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J. Lab. clin. Med 1980; 95: 950-958.
    PubMedGoogle Scholar
  • 63 Giustolisi R, Lombardo R, Musso R, Cacciola E. Factor VIII antigen plasma levels in diabetes mellitus. Enhanced endothelial release and storage. Thromb. Haemostas 1980; 44: 46
    PubMedGoogle Scholar
  • 64 Giustolisi R, Lombardo R, Musso R, Cacciola E. Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects. Thromb. Haemostas 1982; 47: 293
    PubMedGoogle Scholar
  • 65 Grignani G, Gamba G, Biancardi M, Geroldi D, Ferrari E, Bossolo P. A, Cinquini C, de Narco R. Studies of the prethrombotic state of patients with maturity-onset diabetes mellitus undergoing different hypoglycemic treatments. Thromb. Haemostas 1979; 42: 486
    PubMedGoogle Scholar
  • 66 Grignani G, Gamba G, Geroldi D, Pacchiarini L, Solerte B, Ferrari E, Ascari E. Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications. Thromb. Haemostas 1981; 46: 648-651.
    PubMedGoogle Scholar
  • 67 Gurewich V, Lipinska I, Pulini M, Gordon E, Lipinski B. Fibrinogen, fibrinogen heterogeneity and fibrinolytic activity in diabetes mellitus. Thromb. Haemostas 1977; 38: 103
    PubMedGoogle Scholar
  • 68 Gurewich V, Lipinska I. Lower molecular weight fibrinogen and non-clottable fibrinogen derivatives in diabetes mellitus. Thrombos. Res 1981; 22: 533-541.
    PubMedGoogle Scholar
  • 69 Halushka P. V, Lurie D, Colwell J. A. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. New Engl. J. Med 1977; 297: 1306-1310.
    CrossrefPubMedGoogle Scholar
  • 70 Halushka P. V, Rogers R. C, Loadholt C. B, Colwell J. A. Increased platelet thromboxane synthesis in diabetes mellitus. J. Lab. clin. Med 1981; 97: 87-96.
    PubMedGoogle Scholar
  • 71 Harrison H. E, Reece A. H, Johnson M. Effect of insulin treatment on prostacyclin in experimental diabetes. Diabetologia 1980; 18: 65-68.
    CrossrefPubMedGoogle Scholar
  • 72 Hassanein A, El-Garf A, El-Baz Z. Platelet aggregation in diabetes mellitus and effect of insulin in vivo on aggregation. Thrombos. Diathes. Haemorrh 1972; 27: 114-120.
    PubMedGoogle Scholar
  • 73 Heath H, Bridgen W. D, Canever J. V, Pollock J, Hunter P. R, Kelsey J. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 1971; 7: 308-315.
    CrossrefPubMedGoogle Scholar
  • 74 Heischmann A. J, Bierenbaum M. L, Stier A, Somol S. H, Watson P. B. In vivo platelet function in diabetes mellitus. Thromb. Res 1976; 9: 467
    CrossrefPubMedGoogle Scholar
  • 75 Hellem A. J. Adenosine diphosphate induced platelet adhesiveness in diabetes mellitus with complications. Acta med. Scand 1971; 190: 291-295.
    PubMedGoogle Scholar
  • 76 Janka H. U, Standi E. Thrombozytenaggregation im diabetischen Koma: Beziehungen zum Gehalt von zyklischem AMP und zur Prostazyklin stimulierbaren Adenylatzyklase-Aktivität der Thrombozyten. Intensivmed 1979; 16: 275-277.
    PubMedGoogle Scholar
  • 77 Johnson M, Harrison H. E, Raftery A. R, Elder J. B. Vascular prostacyclin may be reduced in diabetics in man. Lancet 1979; 1: 325-326.
    PubMedGoogle Scholar
  • 78 Jones R. L, Peterson Ch. M. Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon. J. Clin. Invest 1979; 63: 485-493.
    CrossrefPubMedGoogle Scholar
  • 79 Kazmier F. J, Owen Ch.A, O’Fallon W. M, Palumbo P. J, Bowie E. J. W. Willebrand antigen (VIII R:Ag) and ristocetin-cofactor (VIII :RWF) in atherosclerosis and diabetes mellitus. Circulation, Suppl 1979; 2: S. 1060
    PubMedGoogle Scholar
  • 80 Kazmier F. J, Fuster V, Chesebro J. H, O’Fallon W. M, Palumbo P. J. Platelet survival half-life in diabetes mellitus with and without peripheral arterial occlusion disease. Thromb. Haemostas 1979; 42: 384
    PubMedGoogle Scholar
  • 81 Kazmier F. J, Bowie E. J. W, O’Fallon W. M, Palumbo P. J. Platelet factor 4 (PG4) and beta-thromboglobulin (beta-TG) in atherosclerosis and diabetes mellitus. Thrombos. Haemostas 1981; 46: S.79 Abstr
    PubMedGoogle Scholar
  • 82 Kreuz W, Jung R, Kollmann F. Veränderungen der Hämostase bei Kindern mit Diabetes. In Vorbereitung. 1983
    PubMedGoogle Scholar
  • 83 Krzywanek H. K, Breddin K, Scharrer I, Kutschera J. Enhanced platelet aggregation as a risk factor for thromboembolic complications in atherosclerosis?. In Schettler G, Weizel A. (Eds) Atherosclerosis III 283-285. Springer; Berlin – Heidelberg – New York: 1974
    Google Scholar
  • 84 Krzywanek H. J. Gesteigerte Plättchenaggre-gation im PAT am Beispiel des Diabetes mellitus. Korrelation dieser Befunde mit den Ergebnissen anderer Aggregationstests. In Breddin H. K. (Ed.) Prostaglandine und Plattchenfunktion Schattauer; Stuttgart – New York: 1978: 127-133.
    Google Scholar
  • 85 Krzywanek H. J, Coutandin K, Friedrich J, Breddin K. PARD – A prospective study on the development of vascular complications in diabetics. Thromb. Haemostas 1979; 42: 484
    PubMedGoogle Scholar
  • 86 Krzywanek H. J, Ziemen M, Weichert W. PARD – Platelet aggregation: A risk factor in diabetes mellitus. Monte Carlo, Sixth Congr. on thrombosis of the league against thromboembolic diseases. 1980: S. 160
    PubMedGoogle Scholar
  • 87 Kwaan H. C, Colwell J. A, Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes 1972; 21: 108-113.
    CrossrefPubMedGoogle Scholar
  • 88 Kwaan H. C, Colwell J. A, Cruz S, Suwanwela N, Dobbie J. G. Increased platelet aggregation in diabetes mellitus. J. Lab. clin. Med 1972; 80: 236-247.
    PubMedGoogle Scholar
  • 89 Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M. Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thrombos. Res 1980; 19: 823-830.
    CrossrefPubMedGoogle Scholar
  • 90 Lars-Olof A, Nilsson J. M. On fibrinolysis in diabetes mellitus. Acta Med. scand 1975; 298: 101-106.
    PubMedGoogle Scholar
  • 91 Lecrubier C, Scarabin P. Y, Grauso F, Samama M. Platelet aggregation related to age in diabetes mellitus. Haemostasis 1980; 9: 43-51.
    PubMedGoogle Scholar
  • 92 Lee H, Paton R. C, Passa P, Caen J. P. Fibrinogen binding and ADP-induced aggregation in platelets from diabetic subjects. Thrombos. Res 1981; 24: 143-150.
    CrossrefPubMedGoogle Scholar
  • 93 Levin R. D, Kwaan H. C, Dobbie J. G, Fetkenhour D. L, Traisman H. S. Partial purification and studies of the plasma cofactor that potentiates platelet aggregation in diabetes mellitus. J. Lab. clin. Med 1981; 98: 519-526.
    PubMedGoogle Scholar
  • 94 Lipinska I, Lipinski B, Gurewich V. Reversible inhibition of euglobulin fibrinolytic activity in diabetes mellitus. Thromb. Haemostas 1979; 42: 382 Abstr
    PubMedGoogle Scholar
  • 95 Lucic A, Lepsanovic L, Kulauzov M, Bukvic R. The values of platelet factor 4 in diabetic patients before and after the isometric exercise. Thrombos. Haemostas 1981; 46: 440
    PubMedGoogle Scholar
  • 96 Lufkin E. G, Fass D. N, O’Fallon W. M, Bowie E. J. W. Increased von Willebrand factor in diabetes mellitus. Metabolism 1979; 28: 63-66.
    CrossrefPubMedGoogle Scholar
  • 97 Masperi R, Mussoni L, Bini A, Donati M. B, Chiumello G. Haemostatic variables in uncomplicated diabetic children. Thromb. Haemostas 1980; 43: 227
    PubMedGoogle Scholar
  • 98 Matsuo T, Ohki Y. Classification of platelet aggregation patterns with two ADP solutions (the double-ADP method) and its clinical application to diabetes mellitus. Thrombos. Res 1977; 77: 453-461.
    PubMedGoogle Scholar
  • 99 Matthews J. H, O’Connor J. F, Hearn-shaw J. R, Wood J. K. Beta-thromboglobulin and glycosylated haemoglobin in diabetes mellitus. Scand. J. Haemat 1979; 23: 421-426.
    PubMedGoogle Scholar
  • 100 Mayne E. E, Bridges J. M, Weaver J. A. Platelet adhesiveness, plasma fibrinogen and Factor VIII levels in diabetes mellitus. Diabetologia 1970; 6: 436-440.
    CrossrefPubMedGoogle Scholar
  • 101 McDonald J. W. D, Dupre J, Rodger N. W, Champion M. C, Webb C. D, Ali M. Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thrombos. Res 1982; 28: 705-712.
    CrossrefPubMedGoogle Scholar
  • 102 Mustard J. F, Packham M. A. Platelets and Diabetes mellitus. New Engl. J. Med 1977; 297: 1345-1347.
    CrossrefPubMedGoogle Scholar
  • 103 Nenci G. G, Merante F, Agnelli G, Ballatori E. Aggregazione piastrinica spontanea in vivo e in vitro nei diabetici e nei vasculopatici. Catania, 1980, 6. Congr. Naz. Soz. Ital. Studio d Emostasi e trombosi., Abstr.
    PubMedGoogle Scholar
  • 104 Nordöy A, Rödset J. M. Platelet phospholipids and their function in patients with juvenile diabetes and maturity onset diabetes. Diabetes 1970; 19: 698-702.
    CrossrefPubMedGoogle Scholar
  • 105 O’Malley B. C, Ward J. D, Timperley W. R, Porter N. R, Preston F. E. Platelet abnormalities in diabetic peripheral neuropathy. Lancet 1975; 2: 1274-1276.
    PubMedGoogle Scholar
  • 106 Ødegaard A. E, Skalhegg B. A, Hellem A. J. Increased activity of »anti-Willebrand-factor« in diabetic plasma. Thrombos. Diathes. Haemorrh 1964; 21: 27-37.
    PubMedGoogle Scholar
  • 107 Oost B. A. van, Veldhuyzen B. F. E, van Houwelingen H. C, Timmermans A. P. M, Sixma J. J. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease. Thrombos. Haemostas. (Stuttgart) 1982; 48: 289-293.
    PubMedGoogle Scholar
  • 108 Pandolfi M, Almer L.-O, Holmberg L. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy. Acta Ophthal 1974; 52: 823-828.
    PubMedGoogle Scholar
  • 109 Pannebakker M. A. G, Jonker J. J. C, de Boer A. C, den Ottolander G. J. H. Platelet function tests in relation to retinopathy and neuropathy in well controlled diabetic patients. Thrombos. Haemostas 1979; 42 S. Abstr 335
    PubMedGoogle Scholar
  • 110 Pareti F. I, Gugliotta L, Mannucci L, Guarini A, Mannucci P. M. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb. Haemostas 1982; 47: 84-89.
    PubMedGoogle Scholar
  • 111 Passa P, Bensoussan D, Levy-Toledano S. Etude de l’aggregation plaquettaire au cours de la retinopathie diabetique. Influence de l’hypophysectomie. Atherosclerosis 1974; 19: 277-285.
    PubMedGoogle Scholar
  • 112 Paton R. C. Platelet survival in diabetes mellitus using an aspirin-labelling technique. Thrombos. Res 1979; 15: 793-802.
    CrossrefPubMedGoogle Scholar
  • 113 Peterson H. D, Gormsen J. Platelet aggregation in diabetes mellitus. Acta med. scand 1978; 203: 125-130.
    PubMedGoogle Scholar
  • 114 Pietsch U, Krzywanek H. J, Breddin K. Ist das Aggregationsverhalten der Thrombozyten ein Indikator für das Fortschreiten athe-rosklerotischer Gefäßwandprozesse bei Diabetikern? Diab. Angiopathien. 1976: S. 229-235.
    PubMedGoogle Scholar
  • 115 Pietsch U, Krzywanek H. J, Breddin H. K. Ist das Aggregationsverhalten der Thrombozyten ein Indikator für das Fortschreiten athe- rosklerotischer Gefäßwandprozesse bei Diabetikern?. In Alexander K, Cachovan M. (Hrsg.) Diabetische Angiopathien 1977: S. 229-235. Witzstrock; Baden-Baden, Köln, New York, Brüssel:
    Google Scholar
  • 116 Porta M, Hilgard P, Kohner E. Adenosine diphosphate-induced platelet shape change in normal and diabetic subjects. Clin. sci 1979; 57: 24
    CrossrefPubMedGoogle Scholar
  • 117 Porta M, McCraw A, Kohner F. M. Inverse relationship between ristocetin co-factor levels and platelet aggregation in insulin dependent diabetes. Thrombos. Res 1982; 25: 507-512.
    CrossrefPubMedGoogle Scholar
  • 118 Preston F. E, Ward J. D, Marcola B. H, Porter N. R, Timperley W. R. Elevated ß-throm-boglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; 2: 238-239.
    PubMedGoogle Scholar
  • 119 Rak K, Beck P, Udvardy M, Pflieger G, Misz M, Boda Z. Plasma levels of beta-throm-boglobulin and factor VIII related antigen in diabetic children and adults. Thrombos. Res 1983; 29: 155-162.
    CrossrefPubMedGoogle Scholar
  • 120 Rathbone R. L, Ardlie N. G, Schwartz C. J. Platelet aggregation and thrombus formation in diabetes mellitus, an in vitro study. Pathology 1970; 2: 307-316.
    CrossrefPubMedGoogle Scholar
  • 121 Rouse E, Cherbit G, Regnault F. Collagen-induced platelet aggregation and collagen glycosyl-transferase activity in diabetic patients. Thrombos. Res 1977; 11: 847-858.
    CrossrefPubMedGoogle Scholar
  • 122 Sagel J, Colwell J. A, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann. Int. Med 1975; 82: 733-738.
    CrossrefPubMedGoogle Scholar
  • 123 Sarji K. E, Lushbaugh W. B, Halushka P. V, Humphrey C. D, Pittman F. E, Gale G. R, Colwell J. A. Action of arachidonic acid on platelets from diabetic and normal subjects. Clin. Res 1977; 25: 53 a
    PubMedGoogle Scholar
  • 124 Scarpello J. H. B, Best L. C, Marcola B. H, McGuire M. B, Preston F. E, Russel R. G. G, Ward J. D. Platelet function studies in diabetics with peripheral neuropathy. Thrombos. Haemostas 1979; 42: 383 (Abstr.)
    PubMedGoogle Scholar
  • 125 Scharrer I, Lenz M, Maas C. The behavior of ristocetin cofactor, F. VIII related antigen, inhibitors of coagulation and platelet aggregation in diabetes. Thrombos. Haemostas 1979; 42: 439
    PubMedGoogle Scholar
  • 126 Sharma M. S. C. Platelet adhesiveness in juvenile onset and maturity onset diabetes mellitus. Thromb. Haemostas 1981; 45: 297
    PubMedGoogle Scholar
  • 127 Shaw S, Pegrum G. D, Wolff S, Ashton W. L. Platelet adhesiveness in diabetes mellitus. J. clin. Path 1967; 20: 845-847.
    CrossrefPubMedGoogle Scholar
  • 128 Silberbauer K, Schernthaner G, Sinzinger H, Winter M, Piza-Katzer H. Juveniler Diabetes mellitus: Verminderte Prostacyclin (PG12)Synthese in der Gefäßwand. VASA 1979; 8: 213-216.
    PubMedGoogle Scholar
  • 129 Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes. New Engl. J. Med 1979; 300: 366-367.
    PubMedGoogle Scholar
  • 130 Stuart M. J, Murphy B. S. S, Oski F. A. A simple nonradioisotope technic for the determination of platelet life-span. New Engl. J. Med 1975; 1: 1310-1312.
    PubMedGoogle Scholar
  • 131 Szirtes M. Platelet aggregation in diabetes mellitus. Adv. Cardiol 1970; 4: 179-186.
    PubMedGoogle Scholar
  • 132 Takeda H, Maeda H, Fukushima H, Nakamura N, Uzawa H. Increased platelet phospholipase activity in diabetic subjects. Thrombos. Res 1981; 24: 131-141.
    CrossrefPubMedGoogle Scholar
  • 133 Tanser A. R. Fibrinolytic response of diabetics and non-diabetics to adrenaline. J. Clin. Path 1967; 20: 231-233.
    CrossrefPubMedGoogle Scholar
  • 134 Tindall H, Paton R. C, Zuzel M, McNicol G. P. Platelet life-span in diabetics with and without retinopathy. Thrombos. Res 1981; 21: 641-648.
    CrossrefPubMedGoogle Scholar
  • 135 Tsianos E. B, Stathakis N. E. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus. Thromb. Haemostas 1980; 44: 130-134.
    PubMedGoogle Scholar
  • 136 Valdorf-Hansen F. Coagulability in diabetics. Acta med. Scand, Suppl 1976; 476: 147-157.
    PubMedGoogle Scholar
  • 137 Voisin Ph, Rouselle D, Duimont C, Drouin P, Stoltz J. F. Evolution of beta-TG level in diabetic patients undergoing artifical pancreas treatment. Thrombos. Haemostas. Abstr 1981; 46: 440
    PubMedGoogle Scholar
  • 138 Voisin Ph, Rousselle D, Drouin P, Stoltz J. F. Betathromboglobulin levels in diabetes mellitus: influence of degenerative lesions and glycemie regulation using an artificial pancreas. Thrombos. Res 1983; 30: 245-255.
    CrossrefPubMedGoogle Scholar
  • 139 Wu K. K, Hoak J. C. A new method for the qualitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926.
    PubMedGoogle Scholar
  • 140 Zahavi J, Jones N. A. G, Betteridge D. J, Leyton J, Galton D. J, Clark S. E, Kakkar V. V. Platelet factor 4, ß-thromboglobu-lin, malondialdehyde formation and blood lipids in patients with diabetes mellitus. Thromb. Haemostas 1979; 42: 334
    PubMedGoogle Scholar
  • 141 Zahavi M, Zahavi J, Kakkar V. V. Modulation of platelet adenosine 3’, 5’ cyclic monophosphate in diabetes mellitus. Haemostasis 1982; 12: 90
    PubMedGoogle Scholar
  • 142 Ziboh V. A, Maruta H, Lord J, Cagle W. D, Lucky W. Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur. J. clin. Invest 1979; 9: 223-228.
    CrossrefPubMedGoogle Scholar
  • 143 Ziemen M, Krzywanek H. J, Coutandin K, Friedrich J, Breddin K. PARD, eine prospektive Studie zur Erfassung von Risikofaktoren bei Diabetikern. In Müller-Wiefei H, Barras J. P, Ehringer H, Krüger M. (Hrsg) Mikrozirkulation und Blutrheologie. Therapie der peripheren arteriellen Verschlußkrankheit G. Witzstrock; Baden-Baden – New York: 1980: 309-311.
    Google Scholar